Sotera Health Company (SHC)

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
United States Revenue	-	629.54M	616.68M
United States Revenue Growth	-	2.08%	4.35%
Canada Revenue	-	221.95M	208.89M
Canada Revenue Growth	-	6.25%	8.77%
Europe Revenue	-	232.18M	196.01M
Europe Revenue Growth	-	18.45%	4.52%
Other Geographic Revenue	-	79.95M	78.86M
Other Geographic Revenue Growth	-	1.38%	0.17%
Revenue (Total)	1.19B	1.16B	1.10B
Revenue (Total) Growth	2.19%	5.74%	4.88%

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Sterigenics Revenue	772.23M	755.78M	697.85M
Sterigenics Revenue Growth	2.18%	8.30%	4.61%
Nordion Revenue	197.07M	187.62M	173.36M
Nordion Revenue Growth	5.04%	8.23%	8.04%
Nelson Labs Revenue	219.84M	220.22M	229.23M
Nelson Labs Revenue Growth	-0.17%	-3.93%	3.40%
Revenue (Other)	1,000.00	3.00K	-1.00K
Revenue (Total)	1.19B	1.16B	1.10B
Revenue (Total) Growth	2.19%	5.74%	4.88%

Revenue Breakdown 2

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Service Revenue	1.01B	995.76M	941.82M
Service Revenue Growth	1.77%	5.73%	4.00%
Product Revenue	175.72M	167.86M	158.62M
Product Revenue Growth	4.68%	5.83%	10.39%
Revenue (Total)	1.19B	1.16B	1.10B
Revenue (Total) Growth	2.19%	5.74%	4.88%

Adjusted EBITDA

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Sterigenics Segment Income	421.30M	412.89M	378.17M
Sterigenics Segment Income Growth	2.04%	9.18%	4.41%
Nordion Segment Income	113.87M	107.58M	101.22M
Nordion Segment Income Growth	5.85%	6.28%	4.70%
Nelson Labs Segment Income	71.45M	73.33M	69.18M
Nelson Labs Segment Income Growth	-2.57%	5.99%	0.06%
Operating Income (Other)	-225.80M	-231.77M	-250.95M
Operating Income (Total)	380.82M	362.03M	297.63M
Operating Income (Total) Growth	5.19%	21.64%	7.57%

Capital Expenditures

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Sterigenics Capital Expenditures	120.88M	99.38M	131.26M
Sterigenics Capital Expenditures Growth	21.63%	-24.28%	-19.50%
Nordion Capital Expenditures	23.73M	21.83M	34.93M
Nordion Capital Expenditures Growth	8.69%	-37.49%	-8.92%
Nelson Labs Capital Expenditures	19.66M	16.80M	12.88M
Nelson Labs Capital Expenditures Growth	16.97%	30.42%	-5.13%

Data Source: Fiscal.ai Last updated: May 5, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 9, 2026

Data Sources Report a data error